Cannabigerol: What Is It? Cannabigerol (CBG) was discovered about the same time as THC, but the latter phytocannabinoid received all of the attention at the time. CBG, as one of the earliest phytocannabinoids to form in a young cannabis plant, has a unique place among the approximately 130 phytocannabinoids discovered so far. It is now being researched for its distinct role and the therapeutic potential it possesses on its own.
What exactly is CBG, and why is it so significant? Bulk CBG Isolate appears as cannabigerolic acid very early in the life of a cannabis plant (CBGA). For a limited period of time, it constitutes the majority of the phytocannabinoid content in the plant, but it quickly converts to the acidic forms of many other cannabinoids found in cannabis. When a plant matures and is harvested, CBG typically accounts for less than 1% of the total cannabinoid content of cannabis flower. Heat, whether from the environment or from intake, transforms phytocannabinoids into active forms that interact with the endocannabinoid system CBG is distinctive in that it is thought to affect both CB1 and CB2 receptors in the endocannabinoid system. This affects various physiological systems, including the central
nervous system and the immunological system. Importantly, Bulk CBG Isolate does not have the same "heady" impact as THC, thus users remain alert.
What are the Advantages of CBG? Although CBG was discovered about the same time as THC, nothing is known about this cannabinoid. CBG's multiple therapeutic advantages show promise in animal investigations. More research is needed to determine whether and how CBG works in humans, although preliminary findings on a variety of symptoms and illnesses are intriguing. CBG may help people with IBD and other painful bowel diseases. CBG's effect on inflammation in the GI system of mice was studied in a 2013 study published in Biochemical Pharmacology. CBG may be effective against drug-resistant Staph infections. CBG kills staph infections, according to a 2008 study published in the Journal of Natural Products, implying that CBG may be anti-bacterial. CBG may potentially be effective against drug-resistant MRSA. CBG may be beneficial in the treatment of glaucoma. CBG was reported to help lower eye pressure in cats with glaucoma in a 2009 study published in the Journal of Ocular Pharmacology. CBG may slow the growth of malignant cells. Bulk CBG Isolate reduced malignant colon cancer cells and tumours in rats, according to a 2014 study published in Carcinogenesis. These possible anti-tumor qualities have also been investigated in other cannabinoids, raising concerns about how the entourage effect may enhance these benefits. The neuroprotective qualities of CBG may slow the progression of Huntington's disease, Alzheimer's disease, dementia, and other comparable diseases. According to a 2015 study published in Neurotherapeutics, CBG delayed the progression of Huntington's disease by fighting never cell degeneration.
CBG Goods that are Available CBG is present in various cannabis strains (also known as cultivars), with some cultivars containing more CBG than others. A cultivar is deemed rich in CBG if it contains 1% or more of the phytocannabinoid. More information can be found on the label of your cannabis flower. CBG can also be isolated and used in the production of cannabis products. CBG Isolate Wholesale, a nearly pure, odourless, and tasteless form of the phytocannabinoid, and distillate, a concentrated form of the phytocannabinoid CBG, which contains other phytocannabinoids, can be blended into tinctures, pills, vape cartridges, and foods. However, CBG Isolate Wholesale items can be difficult to come by. To find out how much CBG Isolate Wholesale is in a cannabis product, ask a Bona Voluntate partner or go to the Bona Voluntate website. The lab test results for your product will show how much CBG or CBGA it contains.
Getting to know the Mother of all cannabinoids CBG occupies a unique position in the field of phytocannabinoids. Bulk CBG Isolate, being the source of all phytocannabinoids in the plant, was the first to develop in a young cannabis plant,
although it was not the first to be studied. However, as research into the potential of phytocannabinoids advances, we are learning more about how CBG, even in trace amounts, can affect the cannabis experience.